Corcept Therapeutics (CORT) Tops Q2 EPS by 6c; Raises Rev Outlook
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $114.47 +3.58%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.13, $0.06 better than the analyst estimate of $0.07. Revenue for the quarter came in at $35.6 million versus the consensus estimate of $32.53 million.
2017 revenue guidance increased by $20 million, to $145-155 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
